Charles Rotimi

Last updated
Charles Rotimi
Charles Rotimi in NHGRI's Oral History Collection.jpg
Rotimi interviewed by the NHGRI Oral History Collection in 2017
Born
Charles Nohuoma Rotimi

1957 (age 65–66)
Benin City
Alma mater University of Benin (BS)
University of Mississippi (MS)
University of Alabama at Birmingham (MPH)
University of Alabama at Birmingham (PhD)
AwardsElected to the National Academy of Medicine (2018)
Scientific career
Institutions Howard University
Loma Linda University
Loyola University Chicago
NIH
Thesis A follow-up study of mortality and a nested case-control study of stomach cancer among foundry and automobile engine manufacturing plant workers  (1991)
Website irp.nih.gov/pi/charles-rotimi

Charles Nohuoma Rotimi (born 1957) is the Scientific Director of the National Human Genome Research Institute (NHGRI). [1] He joined the National Institutes of Health (NIH) in 2008 as the inaugural Director of the Trans-NIH [lower-alpha 1] Center for Research in Genomics and Global Health and was also the chief of the NHGRI's Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch. He works to ensure that population genetics include genomes from African populations and founded the African Society of Human Genetics in 2003 and was elected its first president. Rotimi was instrumental in the launch of the Human Heredity and Health in Africa (H3Africa) with the NIH and the Wellcome Trust. He was elected to the National Academy of Medicine in 2018.

Contents

Early life and education

Rotimi was born in Benin City, Nigeria, and is the second oldest of six children. [2] His mother had no education and his father was a high school English teacher. [2] Rotimi studied at the University of Benin and graduated in 1979. [3] [4] He led the chemistry lab at a high school in Benin. [2] He decided to attend graduate school abroad, and applied to universities in the United Kingdom and United States. [2] He was supported by his family to attend the University of Mississippi, where he studied health care administration. [2] He flew from Nigeria to Mississippi via London, including catching a helicopter from Gatwick Airport to Heathrow Airport. [2] While studying at the University of Mississippi, Rotimi met his wife Deatrice, who was from Chicago. He graduated with a master's degree in 1983. [2] In 1985 he returned to Nigeria and was appointed an administrator at a local health ministry. He returned to America to complete a program in epidemiology at the University of Alabama, and was awarded a full scholarship to complete a doctorate. [2] Rotimi completed his PhD and then spent a year as a postdoc at the Loma Linda University in California. Here he worked on Alzheimer's disease. [2]

Research and career

Rotimi investigates genetics and health disparities, ensuring that African genomes are represented in genome databases. [5] [6] He was appointed as an epidemiologist at Loyola University Chicago, where he worked on cardiovascular disease and obesity in people in the African diaspora. [2] Together with his colleague Richard Cooper, Rotimi recruited 10,000 people to study the prevalence of hypertension in populations of West African descent. [5] He found that hypertension and diabetes rates are significantly higher in African-American populations in Chicago than they are in rural Africa. He attributed this to lifestyle factors, including weight, salt consumption and levels of physical activity. [5]

Rotimi moved to Howard University in 1990, where he worked with Georgia M. Dunston at the National Human Genome Center. Rotimi was promoted[ when? ] to head of genetic epidemiology. [2] Here he studied the impact of the underrepresentation of African and African-American data in genomic datasets. [2] He argued for the use of genomic tools to understand variation in human biology, but pointed out that it is not possible to use genetics to define race; the variation in genomes do not account for the socially defined racial groups and racial self-identity. [7] [8] He compiled genomic data from 6,000 people in 13 language families, identifying 21 global genetic ancestries. [2] The study established that 97 % of people have mixed ancestry, emphasising the problems with labels such as hispanic, black and white. [9] [10] In an interview with The Lancet , Rotimi described inequality as "one of the most outrageous aspects of society". [3]

Rotimi led the African component of the International HapMap Project, which contributed to the 1000 Genomes Project. [2] He recruited three African communities in Kenya and Nigeria, ensuring that African genomes were part of the record. [2] It is understood that homo sapiens originated in Africa, leaving after 100,000 years. [2] During this time much of the genetic evolution had already occurred, and those that emigrated carried a subset of the original genetic diversity. African genomes are the most ancient. [2]

Rotimi looks at the heritability of complex disease. [11] He began to work with Kári Stefánsson in 2007, studying the diabetes risk variant TCF7L2 in West African populations. [12] He demonstrated that both TCF7L2 and its genetic variant HapA increase the risk of diabetes due to their function in energy metabolism. To determine the origins of the sickle cell disease mutation, Rotimi studied the genomes of 3,000 people. [2] He identified that sickle cell emerged around 7,000 years ago in Africa. [2]

Rotimi joined the National Institutes of Health in 2007, where he became founding director of the Trans-NIH Center for Research on Genomics and Global Health. [2] [13] [14] He works with Francis Collins on making genomic studies more inclusive. [2] Rotimi founded the African Society of Human Genetics in 2003. [15] He launched the Human Heredity and Health in Africa (H3Africa) initiative with the African Society of Human Genetics, a $70 million collaboration between the National Institutes of Health and Wellcome Trust. [13] [16] He described the project as a "lifetime achievement". [3]

Awards and honors

Rotimi was elected a member of the National Academy of Medicine (NAM) in 2018. [17] He serves on the editorial boards of Public Health Genomics , Genome Medicine , Clinical Genetics and the Journal of Applied and Translational Genomics. [13] He was awarded the Curt Stern Award from the American Society of Human Genetics in 2019 for his contributions to genetics in African and African-descent populations. [18]

Related Research Articles

The International HapMap Project was an organization that aimed to develop a haplotype map (HapMap) of the human genome, to describe the common patterns of human genetic variation. HapMap is used to find genetic variants affecting health, disease and responses to drugs and environmental factors. The information produced by the project is made freely available for research.

<span class="mw-page-title-main">David Haussler</span> American bioinformatician

David Haussler is an American bioinformatician known for his work leading the team that assembled the first human genome sequence in the race to complete the Human Genome Project and subsequently for comparative genome analysis that deepens understanding the molecular function and evolution of the genome.

<span class="mw-page-title-main">Francis Collins</span> American physician-scientist (born 1950)

Francis Sellers Collins is an American physician-geneticist who discovered the genes associated with a number of diseases and led the Human Genome Project. He served as director of the National Institutes of Health (NIH) in Bethesda, Maryland, from 17 August 2009 to 19 December 2021, serving under three presidents.

Himla (Himladevi) Soodyall is a South African geneticist involved in finding some of the oldest human genetic lines, mainly focusing on Sub-Saharan Africa. Her work on DNA has pointed to southern Africa as the most likely geographic region of origin of the human species.

<span class="mw-page-title-main">Eric D. Green</span> American science administrator

Eric D. Green is an American genomics researcher who had significant involvement in the Human Genome Project. He is the director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH), a position he has held since 2009.

The PhenX Toolkit is a web-based catalog of high-priority measures related to complex diseases, phenotypic traits and environmental exposures. These measures were selected by working groups of experts using a consensus process. PhenX Toolkit's mission is to provide investigators with standard measurement protocols for use in genomic, epidemiologic, clinical and translational research. Use of PhenX measures facilitates combining data from a variety of studies, and makes it easy for investigators to expand a study design beyond the primary research focus. The Toolkit is funded by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) with co-funding by the Office of the Director (OD), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Heart, Lung, and Blood Institute (NHLBI). Continuously funded since 2007, PhenX has received funding from a variety of NIH institutes, including the National Institute on Drug Abuse (NIDA), the National Institute on Mental Health (NIMH), the National Cancer Institute (NCI) and the National Institute on Minority Health and Health Disparities (NIMHD). The PhenX Toolkit is available to the scientific community at no cost.

<span class="mw-page-title-main">Elaine Ostrander</span> American geneticist

Elaine Ann Ostrander is an American geneticist at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds a number of professional academic appointments, currently serving as Distinguished and Senior Investigator and head of the NHGRI Section of Comparative Genomics; and Chief of the Cancer Genetics and Comparative Genomics Branch. She is known for her research on prostate cancer susceptibility in humans and for conducting genetic investigations with the Canis familiaris —the domestic dog— model, which she has used to study disease susceptibility and frequency and other aspects of natural variation across mammals. In 2007, her laboratory showed that much of the variation in body size of domestic dogs is due to sequence changes in a single gene encoding a growth-promoting protein.

Genetic privacy involves the concept of personal privacy concerning the storing, repurposing, provision to third parties, and displaying of information pertaining to one's genetic information. This concept also encompasses privacy regarding the ability to identify specific individuals by their genetic sequence, and the potential to gain information on specific characteristics about that person via portions of their genetic information, such as their propensity for specific diseases or their immediate or distant ancestry.

<span class="mw-page-title-main">Manolis Kellis</span> Greek-born computational biologist

Manolis Kellis is a professor of Computer Science at the Massachusetts Institute of Technology (MIT) in the area of Computational Biology and a member of the Broad Institute of MIT and Harvard. He is the head of the Computational Biology Group at MIT and is a Principal Investigator in the Computer Science and Artificial Intelligence Lab (CSAIL) at MIT.

<span class="mw-page-title-main">Emmanouil Dermitzakis</span> Greek human genetics researcher

Emmanouil Theophilos Dermitzakis is a Greek human geneticist and professor in the Department of Genetic Medicine and Development at the University of Geneva, where he is also Director of the Health 2030 Genome Center. He is an ISI Highly Cited Researcher and an elected member of the European Molecular Biology Organization. He is a member of the Swiss Institute of Bioinformatics, where his research group is focused on the genetics and genomics of complex traits in humans. He has joined GlaxoSmithKline as Vice President, Computational Biology in R&D.

Charmaine DM Royal is an American geneticist and Associate Professor at the Institute for Genome Sciences & Policy and the Department of African and African American Studies at Duke University. She studies the intersections of race, ethnicity, ancestry genetics, and health, especially as they pertain to historically marginalized and underrepresented groups in genetic and genomic research; and genomics and global health. Her major interest is in addressing root causes and implementing sustainable solutions regarding problems of race and racism in research, healthcare, and society. Royal is a Human Heredity and Health in Africa (H3Africa) Independent Expert Committee (IEC) member appointed by the National Institutes of Health (NIH) and is a 2020 Ida Cordelia Beam Distinguished Visiting Professor at the University of Iowa.

Human Heredity and Health in Africa, or H3Africa, is an initiative to study the genomics and medical genetics of African people. Its goals are to build the continent's research infrastructure, train researchers and clinicians, and to study questions of scientific and medical interest to Africans. The H3Africa Consortium was formally launched in 2012 in Addis Ababa and has grown to include research projects across 32 countries, a pan-contintental bioinformatics network, and the first whole genome sequencing of many African ethnolinguistic groups.

<span class="mw-page-title-main">Neil Hanchard</span> Jamaican physician and scientist

Neil Hanchard is a Jamaican physician and scientist who is clinical investigator in the National Human Genome Research Institute (NHGRI), where he leads the Childhood Complex Disease Genomics section. Prior to joining NHGRI, he was an associate professor of molecular and human genetics at the Baylor College of Medicine. He is a fellow of the American College of Medical Genetics and Genomics,. Hanchard's research focuses on the genetics of childhood disease, with an emphasis on diseases impacting global health.

<span class="mw-page-title-main">Vence L. Bonham Jr.</span>

Vence L. Bonham Jr., J.D. is the acting Deputy Director of the National Human Genome Research Institute (NHGRI) of the U. S. National Institutes of Health, and is the leader of the NHGRI Health Disparities Unit. His research focuses on social determinants of health, particularly with regard to the social implications of new genomic knowledge and technologies.

<span class="mw-page-title-main">African Society of Human Genetics</span>

The African Society of Human Genetics (AfSHG) is a learned society and professional membership organization focused on the study of human genetics and genomics in Africans, and open to researchers who are interested in the subject. It has played a role in founding several national genetics societies, and is affiliated with the societies of Cameroon, the Democratic Republic of the Congo, Mali, Egypt, Rwanda, Senegal, South Africa, and Tanzania.

<span class="mw-page-title-main">Tara Matise</span> American geneticist

Tara Matise is an American geneticist at Rutgers University. Since 2018, she has served as chair of the Department of Genetics. Her research interests span computational genetics, data science, and human genetics. She is co-director of the Rutgers University Genetics Coordinating Center.

<span class="mw-page-title-main">Wylie Burke</span> American geneticist

Wylie Burke is a Professor Emerita and former Chair of the Department of Bioethics and Humanities at the University of Washington and a founding co-director of the Northwest-Alaska Pharmacogenomics Research Network, which partners with underserved populations in the Pacific Northwest and Alaska.

<span class="mw-page-title-main">Adebowale A. Adeyemo</span>

Adebowale A. Adeyemo is a Nigerian physician-scientist and genetic epidemiologist specialized in genomics and cardiometabolic disorders. He is the deputy director and chief scientific officer of the Center for Research on Genomics and Global Health at the National Human Genome Research Institute.

References

  1. ↑ "Charles Rotimi, Ph.D., Is NHGRI's New Scientific Director". NIH Intramural Research Program. 2021-10-10. Retrieved 2023-08-09.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 "Genome Collector: A Profile of Charles Rotimi". The Scientist Magazine. Retrieved 2019-05-08.
  3. 1 2 3 Morris, Kelly (2010-10-23). "Charles Rotimi: engaging Africa in human genomic research". The Lancet. 376 (9750): 1383. doi: 10.1016/S0140-6736(10)61943-5 . ISSN   0140-6736. PMID   20971351. S2CID   8083562.
  4. ↑ "Charles N. Rotimi, Ph.D." genome.gov. NHGRI. Retrieved 2019-05-08.
  5. 1 2 3 Cooper, R; Rotimi, C; Ataman, S; McGee, D; Osotimehin, B; Kadiri, S; Muna, W; Kingue, S; Fraser, H (February 1997). "The prevalence of hypertension in seven populations of west African origin". American Journal of Public Health. 87 (2): 160–168. doi:10.2105/ajph.87.2.160. ISSN   0090-0036. PMC   1380786 . PMID   9103091.
  6. ↑ EDT, Jessica Wapner On 7/18/18 at 9:01 AM (2018-07-18). "Cancer scientists have ignored African DNA in the search for cures". Newsweek. Retrieved 2019-05-09.
  7. ↑ Rotimi, Charles N. (2004-10-26). "Are medical and nonmedical uses of large-scale genomic markers conflating genetics and 'race'?". Nature Genetics. 36 (11s): S43–S47. doi: 10.1038/ng1439 . ISSN   1546-1718. PMID   15508002. Closed Access logo transparent.svg
  8. ↑ Keita, S. O. Y.; Kittles, R. A.; Royal, C. D. M.; Bonney, G. E.; Furbert-Harris, P.; Dunston, G. M.; Rotimi, C. N. (2004). "Conceptualizing human variation". Nature Genetics. 36 (11 Suppl): S17–20. doi: 10.1038/ng1455 . ISSN   1061-4036. PMID   15507998. Closed Access logo transparent.svg
  9. ↑ Shriner, Daniel; Rotimi, Charles N.; Baker, Jennifer L. (2017-05-08). "Human ancestry correlates with language and reveals that race is not an objective genomic classifier". Scientific Reports. 7 (1): 1572. Bibcode:2017NatSR...7.1572B. doi:10.1038/s41598-017-01837-7. ISSN   2045-2322. PMC   5431528 . PMID   28484253.
  10. ↑ Lawrence, David (2004-11-20). "A rational basis for race". The Lancet. 364 (9448): 1845–1846. doi: 10.1016/S0140-6736(04)17459-X . ISSN   0140-6736. PMID   15565745. S2CID   42384457.
  11. ↑ Visscher, Peter M.; McCarroll, Steven A.; Mackay, Trudy F. C.; Haines, Jonathan L.; Gibson, Greg; Eichler, Evan E.; Clark, Andrew G.; Boehnke, Michael; Whittemore, Alice S. (2009). "Finding the missing heritability of complex diseases". Nature. 461 (7265): 747–753. Bibcode:2009Natur.461..747M. doi:10.1038/nature08494. ISSN   1476-4687. PMC   2831613 . PMID   19812666.
  12. ↑ Stefánsson, Kári; Rotimi, Charles; Kong, Augustine; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Pedersen, Oluf; Hebebrand, Johannes; Sigurdsson, Gunnar; Christiansen, Claus (2007). "Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution". Nature Genetics. 39 (2): 218–225. doi:10.1038/ng1960. ISSN   1546-1718. PMID   17206141. S2CID   10529476.
  13. 1 2 3 "Principal Investigators". NIH Intramural Research Program. Retrieved 2019-05-08.
  14. ↑ "Center for Research on Genomics and Global Health | NHGRI". genome.gov. Retrieved 2019-05-08.
  15. ↑ "About – AfSHG – African Society of Human Genetics" . Retrieved 2019-05-08.
  16. ↑ "Human Heredity and Health in Africa (H3Africa) – AfSHG – African Society of Human Genetics" . Retrieved 2019-05-08.
  17. ↑ "National Academy of Medicine Elects 85 New Members". nam.edu. National Academy of Medicine. 2018-10-15. Retrieved 2019-05-08.
  18. ↑ "ASHG Honors Charles Rotimi & Sarah Tishkoff with 2019 Curt Stern Award | ASHG". www.ashg.org. 22 July 2019. Retrieved 2019-07-25.

Notes

  1. ↑ "Trans" as in "Trans-National"
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.